Metformin attenuates depressive-like behaviour of methamphetamine withdrawal in mice: A mechanistic approach

References

• Amiri S, Haj-Mirzaian A, Momeny M, Amini-Khoei H, Rahimi-Balaei M, Poursaman S, Rastegar M, Nikoui V, Mokhtari T, Ghazi-Khansari M, et al. 2017. Streptozotocin induced oxidative stress, innate immune system responses and behavioral abnormalities in male mice. Neuroscience. 340:373–383.
   PubMedGoogle Scholar
• Benzie IF, Strain JJ. 1996. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 239(1):70–76.
   PubMed Web of Science ®Google Scholar
• Bussink C, Carpentier C, Davalos L, Davis P, Duran-Martinez A, Eichinger N, Flanders J, Korenblik A, Laenen F, Lemohieu J. 2016. United Nations office on drugs and crime, World Drug Report. New York.
   Google Scholar
• Carmena A, Granado N, Ares-Santos S, Alberquilla S, Tizabi Y, Moratalla R. 2015. Methamphetamine-induced toxicity in indusium griseum of mice is associated with astro- and microgliosis. Neurotox Res. 27(3):209–216.
   PubMedGoogle Scholar
• Chen C-C, Lin J-T, Cheng Y-F, Kuo C-Y, Huang C-F, Kao S-H, Liang Y-J, Cheng C-Y, Chen H-M. 2014. Amelioration of LPS-induced inflammation response in microglia by AMPK activation. Biomed Res Int. 2014:692061.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou T, Guo A-M, Chen W-B, Lin D, Liu Z-Y, Fei E-K. 2020. Metformin ameliorates lipopolysaccharide-induced depressive-like behaviors and abnormal glutamatergic transmission. Biology. 9(11):359.
   PubMedGoogle Scholar
• Du S-H, Qiao D-F, Chen C-X, Chen S, Liu C, Lin Z, Wang H, Xie W-B. 2017. Toll-like receptor 4 mediates methamphetamine-induced neuroinflammation through caspase-11 signaling pathway in astrocytes. Front Mol Neurosci. 10:409.
   PubMedGoogle Scholar
• Ershadi ASB, Amini-Khoei H, Hosseini M-J, Dehpour AR. 2021. SAHA improves depressive symptoms, cognitive impairment and oxidative stress: rise of a new antidepressant class. Neurochem Res. 46(5):1252–1263.
   PubMedGoogle Scholar
• Fang W, Zhang J, Hong L, Huang W, Dai X, Ye Q, Chen X. 2020. Metformin ameliorates stress-induced depression-like behaviors via enhancing the expression of BDNF by activating AMPK/CREB-mediated histone acetylation. J Affect Disord. 260:302–313.
   PubMed Web of Science ®Google Scholar
• Gao X-J, Yuan K, Cao L, Yan W, Luo Y-X, Jian M, Liu J-F, Fang Q, Wang J-S, Han Y. 2017. AMPK signaling in the nucleus accumbens core mediates cue-induced reinstatement of cocaine seeking. Sci Rep. 7(1):1–12.
   PubMedGoogle Scholar
• Ghavimi H, Azarfardian A, Maleki-Dizaji N, Hassanzadeh K, Ghanbarzadeh S, Charkhpour M. 2015. Acute administration of pioglitazone attenuates morphine withdrawal syndrome in rat: a novel role of pioglitazone. Drug Res. 65(3):113–118.
   Google Scholar
• Ghavimi H, Bayani Ershadi AS, Dastvar S, Hosseini M-J. 2021. The effects of minocycline in improving of methamphetamine withdrawal syndrome in male mice. Drug Chem Toxicol. 2021:1–9.
   Google Scholar
• Ghavimi H, Sheidaei S, Vaez H, Zolali E, Asgharian P, Hamishehkar H. 2018. Metformin-attenuated sepsis-induced oxidative damages: a novel role for metformin. Iran J Basic Med Sci. 21(5):469.
   PubMed Web of Science ®Google Scholar
• Gonzales R, Mooney L, Rawson RA. 2010. The methamphetamine problem in the United States. Annu Rev Public Health. 31:385–398.
   PubMed Web of Science ®Google Scholar
• Guo M, Mi J, Jiang QM, Xu JM, Tang YY, Tian G, Wang B. 2014. Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus. Clin Exp Pharmacol Physiol. 41(9):650–656.
   PubMed Web of Science ®Google Scholar
• Hammad AM, Ibrahim YA, Khdair SI, Hall FS, Alfaraj M, Jarrar Y, Abed AF. 2021. Metformin reduces oxandrolone- induced depression-like behavior in rats via modulating the expression of IL-1β, IL-6, IL-10 and TNF-α. Behav Brain Res. 414:113475.
   PubMedGoogle Scholar
• Han DD, Gu HH. 2006. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol. 6(1):6–7.
   PubMedGoogle Scholar
• Han Y, Jiang C, Tang J, Wang C, Wu P, Zhang G, Liu W, Jamangulova N, Wu X, Song X. 2014. Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling. Eur J Pain. 18(10):1458–1470.
   PubMed Web of Science ®Google Scholar
• Hosseini M-J, Sadat-Mahaleh SA, Ghavimi H. 2021. Selegiline alleviates the depressive-like behaviors of methamphetamine withdrawal syndrome through modulating mitochondrial function and energy hemostasis. Pharm Sci.
   Google Scholar
• Howell JJ, Hellberg K, Shaw RJ, Manning BD. 2014. Mechanisms and consequences of hepatic regulation of mTORC1 by metformin. Cancer Metab. 2(S1):1–1.
   PubMedGoogle Scholar
• Jeon S-M. 2016. Regulation and function of AMPK in physiology and diseases. Exp Mol Med. 48(7):e245.
   PubMed Web of Science ®Google Scholar
• Keshavarzi S, Kermanshahi S, Karami L, Motaghinejad M, Motevalian M, Sadr S. 2019. Protective role of metformin against methamphetamine induced anxiety, depression, cognition impairment and neurodegeneration in rat: the role of CREB/BDNF and Akt/GSK3 signaling pathways. Neurotoxicology. 72:74–84.
   PubMed Web of Science ®Google Scholar
• Krasnova IN, Cadet JL. 2009. Methamphetamine toxicity and messengers of death. Brain Res Rev. 60(2):379–407.
   PubMedGoogle Scholar
• Lee YY, Park J-S, Lee E-J, Lee S-Y, Kim D-H, Kang JL, Kim H-S. 2015. Anti-inflammatory mechanism of ginseng saponin metabolite Rh3 in lipopolysaccharide-stimulated microglia: critical role of 5′-adenosine monophosphate-activated protein kinase signaling pathway. J Agric Food Chem. 63(13):3472–3480.
   PubMedGoogle Scholar
• Liu C-M, Yang W, Ma J-Q, Yang H-X, Feng Z-J, Sun J-M, Cheng C, Jiang H. 2018. Dihydromyricetin inhibits lead-induced cognitive impairments and inflammation by the adenosine 5′-monophosphate-activated protein kinase pathway in mice. J Agric Food Chem. 66(30):7975–7982.
   PubMedGoogle Scholar
• Loftis JM, Janowsky A. 2014. Neuroimmune basis of methamphetamine toxicity. Int Rev Neurobiol. 118:165–197.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Bianchi G, Tomassetti S, Zoli M, Melchionda N. 2001. Metformin in non-alcoholic steatohepatitis. The Lancet. 358(9285):893–894.
   PubMed Web of Science ®Google Scholar
• Oliver CN, Ahn B-W, Moerman EJ, Goldstein S, Stadtman ER. 1987. Age-related changes in oxidized proteins. J Biol Chem. 262(12):5488–5491.
   PubMed Web of Science ®Google Scholar
• Pan Y, Sun X, Jiang L, Hu L, Kong H, Han Y, Qian C, Song C, Qian Y, Liu W. 2016. Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation. J Neuroinflammation. 13(1):1–12.
   PubMedGoogle Scholar
• Park SY, Choi MH, Li M, Li K, Park G, Choi Y-W. 2018. AMPK/Nrf2 signaling is involved in the anti-neuroinflammatory action of Petatewalide B from Petasites japonicus against lipopolysaccharides in microglia. Immunopharmacol Immunotoxicol. 40(3):232–241.
   PubMed Web of Science ®Google Scholar
• Peixoto CA, de Oliveira WH, da Racho Araújo SM, Nunes AKS. 2017. AMPK activation: role in the signaling pathways of neuroinflammation and neurodegeneration. Exp Neurol. 298(Pt A):31–41.
   PubMedGoogle Scholar
• Pirnia B, Masoudi R, Sefidrood M, Zarghami E, Pirnia K, Malekanmehr P. 2021. Effect of metformin on cigarette withdrawal syndrome and abstinence in lung cancer patients; a double-blind placebo-controlled trial. Int J Cancer Manag. 14(5):e110775.
   Google Scholar
• Rasgon N, Carter M, Elman S, Bauer M, Love M, Korenman S. 2002. Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review. Curr Drug Targ Immune Endocr Metabol Disord. 2(1):97–102.
   PubMedGoogle Scholar
• Rusyniak DE. 2011. Neurologic manifestations of chronic methamphetamine abuse. Neurol Clin. 29(3):641–655.
   PubMedGoogle Scholar
• Sarkaki A, Farbood Y, Badavi M, Khalaj L, Khodagholi F, Ashabi G. 2015. Metformin improves anxiety-like behaviors through AMPK-dependent regulation of autophagy following transient forebrain ischemia. Metab Brain Dis. 30(5):1139–1150.
   PubMed Web of Science ®Google Scholar
• Shin E-J, Tran H-Q, Nguyen P-T, Jeong JH, Nah S-Y, Jang C-G, Nabeshima T, Kim H-C. 2018. Role of mitochondria in methamphetamine-induced dopaminergic neurotoxicity: involvement in oxidative stress, neuroinflammation, and Pro-apoptosis-A Review. Neurochem Res. 43(1):66–78.
   PubMed Web of Science ®Google Scholar
• Shirooie S, Sahebgharani M, Esmaeili J, Dehpour AR. 2019. In vitro evaluation of effects of metformin on morphine and methadone tolerance through mammalian target of rapamycin signaling pathway. J Cell Physiol. 234(3):3058–3066.
   PubMed Web of Science ®Google Scholar
• Shivavedi N, Kumar M, Tej GNVC, Nayak PK. 2017. Metformin and ascorbic acid combination therapy ameliorates type 2 diabetes mellitus and comorbid depression in rats. Brain Res. 1674:1–9.
   PubMedGoogle Scholar
• Siciliano CA, Calipari ES, Ferris MJ, Jones SR. 2014. Biphasic mechanisms of amphetamine action at the dopamine terminal. J Neurosci. 34(16):5575–5582.
   PubMedGoogle Scholar
• Sonei N, Amiri S, Jafarian I, Anoush M, Rahimi-Balaei M, Bergen H, Haj-Mirzaian A, Hosseini M-J. 2017. Mitochondrial dysfunction bridges negative affective disorders and cardiomyopathy in socially isolated rats: pros and cons of fluoxetine. World J Biol Psychiatry. 18(1):39–53.
   PubMed Web of Science ®Google Scholar
• Steinberg GR, Kemp BE. 2009. AMPK in health and disease. Physiol Rev. 89(3):1025–1078.
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang M, Chen K, Chen B, Zhao Y, Gong H, Zhao X, Qi R. 2018. Suppression of TLR4 activation by resveratrol is associated with STAT3 and Akt inhibition in oxidized low-density lipoprotein-activated platelets. Eur J Pharmacol. 836:1–10.
   PubMed Web of Science ®Google Scholar
• Sun H, Zhu X, Lin W, Zhou Y, Cai W, Qiu L. 2017. Interactions of TLR4 and PPARγ, dependent on AMPK signalling pathway contribute to anti-inflammatory effects of vaccariae hypaphorine in endothelial cells. Cell Physiol Biochem. 42(3):1227–1239.
   PubMedGoogle Scholar
• Tsoyi K, Jang HJ, Nizamutdinova IT, Kim YM, Lee YS, Kim HJ, Seo HG, Lee JH, Chang KC. 2011. Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice. Br J Pharmacol. 162(7):1498–1508.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang Y-H, Guo C, Gao H-L, Zhong M-L, Huang T-T, Liu N-N, Guo R-F, Lan T, Zhang W, et al. 2018. Tetrathiomolybdate treatment leads to the suppression of inflammatory responses through the TRAF6/NFκB pathway in LPS-stimulated BV-2 microglia. Front Aging Neurosci. 10:9.
   PubMedGoogle Scholar
• Wu L-H, Lin C, Lin H-Y, Liu Y-S, Wu CY-J, Tsai C-F, Chang P-C, Yeh W-L, Lu D-Y. 2016. Naringenin suppresses neuroinflammatory responses through inducing suppressor of cytokine signaling 3 expression. Mol Neurobiol. 53(2):1080–1091.
   PubMedGoogle Scholar
• Wu X-F, Wang A-F, Chen L, Huang E-P, Xie W-B, Liu C, Huang W-Y, Chen C-X, Qiu P-M, Wang H-J. 2014. S-nitrosylating protein disulphide isomerase mediates α-synuclein aggregation caused by methamphetamine exposure in PC12 cells. Toxicol Lett. 230(1):19–27.
   PubMedGoogle Scholar
• Yang X, Wang Y, Li Q, Zhong Y, Chen L, Du Y, He J, Liao L, Xiong K, Yi C-X, et al. 2018. The main molecular mechanisms underlying methamphetamine- induced neurotoxicity and implications for pharmacological treatment. Front Mol Neurosci. 11:186.
   PubMed Web of Science ®Google Scholar